Fernandez, Manuela .

HRN: 22-49-89  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/21/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/21/2023
01/28/2023
IV
2.25g
Q8H
Sepsis Sec To DM Foot, L
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  Disseminated Systemic Infection    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: